← Back to headlines
Novo Nordisk Considers Bangladesh as Potential Insulin Production Hub
Pharmaceutical giant Novo Nordisk is exploring the possibility of establishing Bangladesh as a key hub for insulin manufacturing, aiming to expand its production capabilities in the region.
2 May, 07:12 — 2 May, 07:12
Sources
Showing 1 of 1 sources
